Скачайте изображение (превью) выбрав качество

320x180 480x360 640x480 1280x720

Ep 17: Rasha Al-Lamee on ORBITA, ISCHEMIA, coronary revascularisation & stable ischemic heart disease

Recorded before the American Heart Association (AHA) Scientific Sessions 2019, Ankur is joined by Rasha K Al-Lamee, Interventional Cardiologist at Imperial College Healthcare NHS Trust in London and Study Director of the Objective Randomised Blinded Investigation with Optimal Medical Therapy of Angioplasty in Stable Angina (ORBITA) trial. Rasha talks about how she got into academia, the significance of her end-of-training PhD, and what led to the genesis of ORBITA. Ankur and Rasha also discuss the findings and unanswered questions of ORBITA, and how recent research in coronary revascularisation and stable ischemic heart disease has (or has not) changed their clinical practice. Finally, in anticipation of its presentation at AHA 2019, Rasha gives an overview of the International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA). Submit your question to Ankur via: podcast@radciffe-group.com. Hosted by @AnkurKalraMD. Produced by @RadcliffeCARDIO.

Follow us:
Twitter:
@AnkurKalraMD hyperlink to
@radcliffeCARDIO hyperlink to

Facebook:
Ankur Kalra MD hyperlink to
Radcliffe Cardiology hyperlink to

YouTube:
Radcliffe Group hyperlink to

More information on Ankur and US Cardiology journal:



Register today for regular updates on other Radcliffe Cardiology projects:


Email us thoughts, comments and questions:
podcast@radcliffe-group.com

Чтобы скачать видео "Parallax | Ep 17: ORBITA, ISCHEMIA, coronary revascularisation & stable ischemic heart disease" передвинте ползунок вправо